InterCure Ltd. Share Price TEL AVIV STOCK EXCHANGE

INCR

IL0011063760

Healthcare Facilities & Services

News in other languages : InterCure Ltd.

02/20/02

Tilray, Inc. : première exportation de cannabis vers Israël

More news

Managers and Directors : InterCure Ltd.

Manager	Title	Age	Since
Alexander Rabinovitch CEO	Chief Executive Officer	55	24/12/2019
Amos Cohen DFI	Director of Finance/CFO	47	01/03/2020
Itai Kabiljo LAW	General Counsel	-	01/04/2022

Director	Title	Age	Since
Lennie Michelson Grinbaum BRD	Director/Board Member	50	03/09/2015
David Salton BRD	Director/Board Member	66	14/12/2014
Alexander Rabinovitch CHM	Chairman	55	13/02/2025

More insiders

InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.

Employees

Sector

Healthcare Facilities & Services

More about the company

Market Cap	19Cr 58Cr 17Cr 16Cr 14Cr 26Cr 1.82TCr 27Cr 183.52Cr 71Cr 928.19Cr 72Cr 71Cr 2.99TCr	P/E 2024	-4.01x	P/E 2025	-4.87x
Enterprise Value	33Cr 99Cr 28Cr 27Cr 24Cr 45Cr 3.11TCr 46Cr 313.74Cr 122.18Cr 1.59TCr 123.35Cr 120.66Cr 5.11TCr	EV / Sales 2024	1.69x	EV / Sales 2025	1.16x
Free-Float	60.83%	Yield 2024 *	-	Yield 2025	-

25/08	InterCure Ltd. announced that it has received ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors.	CI
24/08	Intercure Ltd. Finalizes Settlement for War-Related Indirect Damages with the Israeli Tax Authorities and Compensation Fund the Subsequent War	CI
22/06	InterCure Ltd. announced that it expects to receive ILS 21.711643 million in funding from Bennu Pharma Fund Ltd and other investors.	CI
15/06	InterCure Starts Review of US Medical Cannabis Opportunities; Completes Initial Closing of Botanico Acquisition	MT
15/06	InterCure Ltd. acquired 50% stake of Botanico Ltd.	CI
15/06	InterCure Ltd. completed the acquisition of 50% stake in Botanico Ltd.	CI
01/05	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04/03	InterCure Receives Noncompliance Notice From Nasdaq	MT
04/03	InterCure receives Nasdaq notification regarding minimum bid requirement	RE
19/02	InterCure announces preliminary estimated 2025 revenue of NIS 265 million, positive adjusted EBITDA and cash of NIS 43 million	RE
19/12	InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court	RE
03/11	Cannasoul Analytics Ltd. announced that it expects to receive funding from InterCure Ltd.	CI
03/11	InterCure Ltd. Enters into A Collaboration Agreement with Cannasoul R&D Ltd	CI

24/08	InterCure Finalizes NIS 230 Million (~US$77 Million) Settlement for War-Related Indirect Damages	AQ
19/08	InterCure Ltd. Announces 1-for-5 Reverse Share Split	AQ
22/06	InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds	AQ
15/06	InterCure Initiates Strategic Review of U.S. Medical Cannabis Opportunities Following Historic Federal Rescheduling and Completes the Initial closing of Botanico Acquisition	AQ
01/05	InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
INTERCURE LTD.	+0.22%	-0.51%	-	-	6.39Cr
VILLAGE FARMS INTERNATIONAL, INC.	0.00%	-0.69%	+8.65%	+208.79%	35Cr
ORGANIGRAM GLOBAL INC.	+0.32%	-5.95%	-28.18%	-28.18%	16Cr
CANNARA BIOTECH INC.	+1.01%	+0.50%	+12.36%	+92.31%	14Cr
ASCEND WELLNESS HOLDINGS, INC.	0.00%	+4.76%	-34.33%	-42.86%	8.94Cr
INTERCURE LTD.	+2.47%	-5.78%	-38.72%	-43.80%	6.39Cr
IANTHUS CAPITAL HOLDINGS, INC.	0.00%	0.00%	0.00%	-80.00%	2.53Cr
Average	+0.53%	-1.43%	-13.37%	+17.71%	13.93Cr
Weighted average by Cap.	+0.35%	-0.95%	-6.31%	+88.31%

	2024	2025
Net sales	24Cr 72Cr 21Cr 19Cr 18Cr 33Cr 2.26TCr 33Cr 228.13Cr 89Cr 1.15TCr 90Cr 88Cr 3.72TCr	27Cr 81Cr 23Cr 22Cr 20Cr 37Cr 2.55TCr 38Cr 258.08Cr 100.51Cr 1.31TCr 101.47Cr 99Cr 4.2TCr
Net income	-6.78Cr -20Cr -5.83Cr -5.47Cr -5.01Cr -9.35Cr -640.87Cr -9.42Cr -65Cr -25Cr -327.51Cr -25Cr -25Cr -1.05TCr	-3.57Cr -11Cr -3.07Cr -2.88Cr -2.64Cr -4.92Cr -337.57Cr -4.96Cr -34Cr -13Cr -172.51Cr -13Cr -13Cr -555.59Cr
Net Debt	13Cr 40Cr 11Cr 11Cr 9.81Cr 18Cr 1.25TCr 18Cr 126.8Cr 49Cr 641.31Cr 50Cr 49Cr 2.07TCr	14Cr 41Cr 12Cr 11Cr 10Cr 19Cr 1.29TCr 19Cr 130.22Cr 51Cr 658.63Cr 51Cr 50Cr 2.12TCr

InterCure Ltd. Share Price TEL AVIV STOCK EXCHANGE

Stocks

INCR

IL0011063760

Healthcare Facilities & Services

Valuation : InterCure Ltd.

Latest news : InterCure Ltd.

Press Releases : InterCure Ltd.

News in other languages : InterCure Ltd.

Quotes and Performance

Managers and Directors : InterCure Ltd.

Medical Farming

Financials

Company Profile